Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedrich W Kreth

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Acta Neuropathologica|January 24, 2013
In human glioblastomas transcript elongation by alternative polyadenylation and miRNA targeting is a potent mechanism of MGMT silencingSimone Kreth, Elisabeth Limbeck, Ludwig C Hinske, et al.
Lasers in Surgery and Medicine|June 15, 2007
Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IXTobias J Beck, Friedrich W Kreth, Wolfgang Beyer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2006
Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods?Gabriele Pöpperl, Friedrich W Kreth, Jochen Herms, et al.
Journal of Neuropathology and Experimental Neurology|October 10, 2009
Novel molecular stereotactic biopsy procedures reveal intratumoral homogeneity of loss of heterozygosity of 1p/19q and TP53 mutations in World Health Organization grade II gliomasNiklas Thon, Sabina Eigenbrod, Eva M Grasbon-Frodl, et al.
Plos One|March 3, 2011
O-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylationSimone Kreth, Niklas Thon, Sabina Eigenbrod, et al.
Molecular Imaging|March 16, 2013
[18F]fluoroethyltyrosine-positron emission tomography-based therapy monitoring after stereotactic iodine-125 brachytherapy in patients with recurrent high-grade gliomaNathalie L Jansen, Bogdana Suchorska, Silke B Schwarz, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 24, 2010
Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomideNiklas Thon, Sabina Eigenbrod, Eva M Grasbon-Frodl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 4, 2007
FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour gradingGabriele Pöpperl, Friedrich W Kreth, Jan H Mehrkens, et al.
Neurology|January 23, 2015
Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBMBogdana Suchorska, Nathalie L Jansen, Jennifer Linn, et al.
Acta Neurochirurgica|May 6, 2014
Molecular stereotactic biopsy technique improves diagnostic accuracy and enables personalized treatment strategies in glioma patientsSabina Eigenbrod, Raimund Trabold, David Brucker, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Acta Neuropathologica|January 24, 2013
In human glioblastomas transcript elongation by alternative polyadenylation and miRNA targeting is a potent mechanism of MGMT silencingSimone Kreth, Elisabeth Limbeck, Ludwig C Hinske, et al.
Lasers in Surgery and Medicine|June 15, 2007
Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IXTobias J Beck, Friedrich W Kreth, Wolfgang Beyer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2006
Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods?Gabriele Pöpperl, Friedrich W Kreth, Jochen Herms, et al.
Journal of Neuropathology and Experimental Neurology|October 10, 2009
Novel molecular stereotactic biopsy procedures reveal intratumoral homogeneity of loss of heterozygosity of 1p/19q and TP53 mutations in World Health Organization grade II gliomasNiklas Thon, Sabina Eigenbrod, Eva M Grasbon-Frodl, et al.
Plos One|March 3, 2011
O-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylationSimone Kreth, Niklas Thon, Sabina Eigenbrod, et al.
Molecular Imaging|March 16, 2013
[18F]fluoroethyltyrosine-positron emission tomography-based therapy monitoring after stereotactic iodine-125 brachytherapy in patients with recurrent high-grade gliomaNathalie L Jansen, Bogdana Suchorska, Silke B Schwarz, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 24, 2010
Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomideNiklas Thon, Sabina Eigenbrod, Eva M Grasbon-Frodl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 4, 2007
FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour gradingGabriele Pöpperl, Friedrich W Kreth, Jan H Mehrkens, et al.
Neurology|January 23, 2015
Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBMBogdana Suchorska, Nathalie L Jansen, Jennifer Linn, et al.
Acta Neurochirurgica|May 6, 2014
Molecular stereotactic biopsy technique improves diagnostic accuracy and enables personalized treatment strategies in glioma patientsSabina Eigenbrod, Raimund Trabold, David Brucker, et al.
Pageof 3